These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23849588)

  • 21. Efficacy of a surveillance program for early detection of hepatocellular carcinoma.
    Zoli M; Magalotti D; Bianchi G; Gueli C; Marchesini G; Pisi E
    Cancer; 1996 Sep; 78(5):977-85. PubMed ID: 8780534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.
    Fasani P; Sangiovanni A; De Fazio C; Borzio M; Bruno S; Ronchi G; Del Ninno E; Colombo M
    Hepatology; 1999 Jun; 29(6):1704-7. PubMed ID: 10347111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients.
    Tanaka H; Tsukuma H; Kasahara A; Hayashi N; Yoshihara H; Masuzawa M; Kanda T; Kashiwagi T; Inoue A; Kato M; Oshima A; Kinoshita Y; Kamada T
    Int J Cancer; 2000 Sep; 87(5):741-9. PubMed ID: 10925370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients.
    Liang KH; Zhang P; Lin CL; Wang SC; Hu TH; Yeh CT; Su GL
    Dig Dis Sci; 2020 Jul; 65(7):2130-2139. PubMed ID: 31677071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation.
    Larcos G; Sorokopud H; Berry G; Farrell GC
    AJR Am J Roentgenol; 1998 Aug; 171(2):433-5. PubMed ID: 9694470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Velázquez RF; Rodríguez M; Navascués CA; Linares A; Pérez R; Sotorríos NG; Martínez I; Rodrigo L
    Hepatology; 2003 Mar; 37(3):520-7. PubMed ID: 12601348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development.
    Benvegnù L; Noventa F; Bernardinello E; Pontisso P; Gatta A; Alberti A
    Gut; 2001 Jan; 48(1):110-5. PubMed ID: 11115831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffuse cirrhosis-like hepatocellular carcinoma: a clinically and radiographically undetected variant mimicking cirrhosis.
    Jakate S; Yabes A; Giusto D; Naini B; Lassman C; Yeh MM; Ferrell LD
    Am J Surg Pathol; 2010 Jul; 34(7):935-41. PubMed ID: 20463569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
    Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An analysis of clinical characteristics and risk factors of cirrhosis-related hepatocellular carcinomas in patients with hepatitis C virus infection].
    Wu CH; Tian GS; Xu XY; Yu YY; Huang T
    Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):210-4. PubMed ID: 18364082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
    Bolondi L; Sofia S; Siringo S; Gaiani S; Casali A; Zironi G; Piscaglia F; Gramantieri L; Zanetti M; Sherman M
    Gut; 2001 Feb; 48(2):251-9. PubMed ID: 11156649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
    Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
    J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection.
    Shibata M; Morizane T; Uchida T; Yamagami T; Onozuka Y; Nakano M; Mitamura K; Ueno Y
    Lancet; 1998 Jun; 351(9118):1773-7. PubMed ID: 9635950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient elastography for the detection of hepatocellular carcinoma in viral C liver cirrhosis. Is there something else than increased liver stiffness?
    Feier D; Lupsor Platon M; Stefanescu H; Badea R
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):283-9. PubMed ID: 24078985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection.
    Toyoda H; Kumada T; Tada T; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Ito T
    J Gastroenterol Hepatol; 2015 Jul; 30(7):1183-9. PubMed ID: 25678094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication.
    Huang CF; Yeh ML; Tsai PC; Hsieh MH; Yang HL; Hsieh MY; Yang JF; Lin ZY; Chen SC; Wang LY; Dai CY; Huang JF; Chuang WL; Yu ML
    J Hepatol; 2014 Jul; 61(1):67-74. PubMed ID: 24613362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.